Criminal-cartel allegations against pharmaceutical company Alkaloids of Australia could attract the attention of regulators in Europe and China, with evidence before a local Sydney court suggesting that potentially anticompetitive meetings took place on their turf. In local-court documents seen by MLex, of the 33 offenses allegedly committed by Alkaloids of Australia and